/Tag:InterveXion Therapeutics

Michael Owens, Ph.D., Named Arkansas Research Alliance Fellow

Dec. 11, 2015 | The Arkansas Research Alliance named UAMS’ Michael Owens, Ph.D., an ARA Fellow during a news conference Dec. 10 at the state Capitol. Michael Owens, Ph.D., (second from right) poses for a picture with Arkansas Research Alliance President and CEO Jerry Adams, ARA board chair Sonja Hubbard and Gov. Asa Hutchinson. [...]

By | December 11th, 2015|University News|0 Comments

UAMS Startup Gets $14.5 Million to Develop Drug Therapies for Methamphetamine Users

January 29, 2015 | A University of Arkansas for Medical Sciences (UAMS) BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.

By | January 29th, 2015|UAMS News, University News|0 Comments